APA (7th ed.) Citation

BD, D. X., PhD, X. J., MM, R. S., MM, M. Z., BD, J. W., MM, X. X., . . . Mingfeng Zhao PhD, M. (2022). Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies. SAGE Publishing.

Chicago Style (17th ed.) Citation

BD, Danni Xie, Xin Jin PhD, Rui Sun MM, Meng Zhang MM, Jiaxi Wang BD, Xia Xiong MM, Xiaomei Zhang MM, and MD Mingfeng Zhao PhD. Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies. SAGE Publishing, 2022.

MLA (9th ed.) Citation

BD, Danni Xie, et al. Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies. SAGE Publishing, 2022.